Ceapro Inc V.CZO

Licensing agreement?

[lscfa]

Why not lease agreement? Isn't co. simply building the plant on U of A property?

[Ciao]

This may explain it, https://norrismclaughlin.com/blogs/nred/category/lease-v-license-whats-the-difference Given the relationship between Ceapro and UofA, this approach looks fine.

[Stinzo]

Must be something about company culture that I do not understand ... you announce the licensing of some spaces for scale up but do not provide any idea of cost and timing? For a company that moves quiet slowly, you would expect them to have all this information on hand by now, they have been studying this scale up for 12-24 months? The way I read the article, is that only once this new 5-10 x

[Ciao]

There have been previous slides in presentations which indicate a graph showing equipment scale and equipment grade. My interpretation is that there is some natural overlap between capacity and product status. Clinical study material starts at 10L to 50L and a commercial plant capacity starts at 50L to 100L.  There is also a PGX development and milestone slide that Gilles discussed in the HCW

[Ciao]

Gilles has stated before that if they receive positive bioavailabitly results, they will move ahead to out license the tech. It'll be up to companies to partner with CZO and conduct any efficacy studies they wish as each bioactive would require their own study.  In the SCD interview at the 1hr 14 min. mark, Gilles said he would present positive PGX alginate CoQ10 bioavailability data to

[prophetoffactz]

"Gilles has stated before that if they receive positive bioavailabitly results, they will move ahead to out license the tech. It'll be up to companies to partner with CZO and conduct any efficacy studies they wish as each bioactive would require their own study." Today's news release suggests CZO may need this scale-up for formulation and testing with a partner. "This next

[Ciao]

I'm not sure what has changed in a few months and precludes them from at least signing agreements for co-development of new chemical complexes given that there is capacity to produce samples for clinical and efficacy testing. Aren't these potential commercial customers going to take a step wise approach to prove out desired outcomes of these chemical complexes with some small scale studies

[prophetoffactz]

"I'm not sure what has changed in a few months and precludes them from at least signing agreements for co-development of new chemical complexes given that there is capacity to produce samples for clinical and efficacy testing. Aren't these potential commercial customers going to take a step wise approach to prove out desired outcomes of these chemical complexes with some small scale

[Ciao]

The PGX demo plant should be at 10L. Scaling up 5 to 10 X takes it to 50 to 100 L which is adequate for commercial production.  It's been said that scaling up was to allow Ceapro to go alone with their PGX YBG immune booster and in parallel the capacity could be used for any commercial PGX alginate or YBG substrates to be loaded with bioactives. So yes, scaling up takes them to

[prophetoffactz]

"The PGX demo plant should be at 10L. Scaling up 5 to 10 X takes it to 50 to 100 L which is adequate for commercial production." How many L was the previous $100 million NPV based on?

[Ciao]

I believe your previous numbers were off. https://stockhouse.com/companies/bullboard/v.czo/ceapro-inc?postid=34895122 The presentation slides call for a 50L plant in 2024. As noted in yesterday's NR this can be internally funded. Which webcast did Gilles mention the $100M NPV, I'll need to view again. I'm thinking $4M takes them to 50L and perhaps up to 100L. 10X that best case is

[lscfa]

Where is the equipment purchased in Sept 2020 at?  Had not yet been disassembled from German R&D facility in January 2021 (due to COVID?). I suspect the large jump in freight costs also has delayed shipment to Canada.  

[Ciao]

I believe it was mentioned in one of the webcasts this year that the equipment is in Boston. Don't know when it arrived.

[Ciao]

correction:  the location of equipment for a "50L capacity" was mentioned in the June AGM, some equipment was said to originate from Boston and the German equipment bought over 2 years ago was still to be imported 

[prophetoffactz]

With the bioavailability study completed CZO now has a destination. With a facility now licensed CZO has a place for scale-up. Since this intermediate level scale-up uses existing equipment and equipment CZO is already familar with and since yeast beta glucan and alginate are relatively easy to process I'm hoping this scale-up happens smoothly and relatively fast. With a facility that could